Overview
Jennifer Temel is an Oncologist practicing medicine in Boston, Massachusetts.
Dr. Temel is highly rated in 13 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Pleuropulmonary Blastoma, and Gastrostomy.
Dr. Temel is board certified in Medical Oncology. She is actively involved in clinical research, co-authoring 287 peer reviewed articles and participating in 11 clinical trials. Dr. Temel is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
55 Fruit St, Boston, MA 02114
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
11 Clinical Trials
Massachusetts General Hospital
Jeremy Abramson is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Abramson is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, B-Cell Lymphoma, Classical Hodgkin Lymphoma, Bone Marrow Aspiration, and Tissue Biopsy. Dr. Abramson is currently accepting new patients.
Office
Edwin Choy is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choy is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Adult Soft Tissue Sarcoma, Liposarcoma, Osteosarcoma, and Synovial Sarcoma. Dr. Choy is currently accepting new patients.
Dana-Farber Cancer Institute, Center For Neuro-Oncology
David Reardon is a Hematologist Oncology specialist and a Hematologist practicing medicine in Boston, Massachusetts. Dr. Reardon is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, Brain Tumor, and Tissue Biopsy. Dr. Reardon is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Reardon is currently accepting new patients.
Dana-Farber Cancer Institute
Matthew Davids is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Davids is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), Small Lymphocytic Lymphoma (SLL), Bone Marrow Aspiration, and Tissue Biopsy. Dr. Davids is currently accepting new patients.
Dana-Farber Cancer Institute
Eric Jacobsen is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Jacobsen is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Peripheral T-Cell Lymphoma, Non-Hodgkin Lymphoma, T-Cell Lymphoma, Reticulohistiocytoma, and Bone Marrow Aspiration. Dr. Jacobsen is currently accepting new patients.
Dana-Farber Cancer Institute
Toni Choueiri is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Choueiri is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, Urothelial Cancer, Nephrectomy, and Orchiectomy. Dr. Choueiri is currently accepting new patients.
Frequently Asked Questions about Dr. Jennifer S. Temel
How do I make an appointment with Dr. Jennifer S. Temel?
You can book an appointment with Dr. Jennifer S. Temel by calling their office at 617-724-0287. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Jennifer S. Temel a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jennifer S. Temel is classified as an Elite expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Jennifer S. Temel specialize in?
While Dr. Jennifer S. Temel is a Oncology, they have specific expertise in Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), and EGFR Positive Lung Cancer. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Jennifer S. Temel participate in research or clinical trials?
Yes. Dr. Jennifer S. Temel has published 287 articles and abstracts on conditions like Lung Cancer. You can view a list of Dr. Jennifer S. Temel's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Jennifer S. Temel accept my insurance?
Dr. Jennifer S. Temel accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-724-0287 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Lung CancerDr. Temel isElite. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)
- Distinguished
- ALK-Positive Non-Small Cell Lung CancerDr. Temel isDistinguished. Learn about ALK-Positive Non-Small Cell Lung Cancer.
- EGFR Positive Lung CancerDr. Temel isDistinguished. Learn about EGFR Positive Lung Cancer.
- Large-Cell Lung CarcinomaDr. Temel isDistinguished. Learn about Large-Cell Lung Carcinoma.
- Lung AdenocarcinomaDr. Temel isDistinguished. Learn about Lung Adenocarcinoma.
- Pleuropulmonary BlastomaDr. Temel isDistinguished. Learn about Pleuropulmonary Blastoma.
- Small Cell Lung Cancer (SCLC)Dr. Temel isDistinguished. Learn about Small Cell Lung Cancer (SCLC).
- Squamous Cell Lung CarcinomaDr. Temel isDistinguished. Learn about Squamous Cell Lung Carcinoma.
- Advanced
- Acute Myeloid Leukemia (AML)Dr. Temel isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Breast CancerDr. Temel isAdvanced. Learn about Breast Cancer.
- LeukemiaDr. Temel isAdvanced. Learn about Leukemia.
- Lung NodulesDr. Temel isAdvanced. Learn about Lung Nodules.
- Experienced
- Anal CancerDr. Temel isExperienced. Learn about Anal Cancer.
- Brain TumorDr. Temel isExperienced. Learn about Brain Tumor.
- Colorectal CancerDr. Temel isExperienced. Learn about Colorectal Cancer.
- GastrostomyDr. Temel isExperienced. Learn about Gastrostomy.
- GliomaDr. Temel isExperienced. Learn about Glioma.
- Gliomatosis CerebriDr. Temel isExperienced. Learn about Gliomatosis Cerebri.
- Liver FailureDr. Temel isExperienced. Learn about Liver Failure.
- MelanomaDr. Temel isExperienced. Learn about Melanoma.
- MesotheliomaDr. Temel isExperienced. Learn about Mesothelioma.
- Metastatic Brain TumorDr. Temel isExperienced. Learn about Metastatic Brain Tumor.
- Neuroendocrine TumorDr. Temel isExperienced. Learn about Neuroendocrine Tumor.
- Pancreatic CancerDr. Temel isExperienced. Learn about Pancreatic Cancer.
- Posterior Fossa TumorDr. Temel isExperienced. Learn about Posterior Fossa Tumor.
- Primitive Neuroectodermal Tumor (PNET)
- Thymic Epithelial TumorDr. Temel isExperienced. Learn about Thymic Epithelial Tumor.